Preventing the recurrence of depression with a Mediterranean diet supplemented with extra-virgin olive oil. The PREDI-DEP trial: study protocol.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
11 02 2019
Historique:
received: 07 06 2018
accepted: 25 01 2019
entrez: 13 2 2019
pubmed: 13 2 2019
medline: 18 12 2019
Statut: epublish

Résumé

The role of dietary patterns in the prevention of unipolar depression has been analyzed in several epidemiological studies. The primary aims of this study are to determine the effectiveness of an extra-olive oil-enriched Mediterranean diet in reducing the recurrence of depression and improving the symptoms of this condition. Multicenter, two-arm, parallel-group clinical trial. Arm 1, extra-virgin olive oil Mediterranean diet; Arm 2, control group without nutritional intervention. Dieticians are in charge of the nutritional intervention and regular contact with the participants. Contacts are made through our web platform ( https://predidep.es/participantes/ ) or by phone. Recurrence of depression is assessed by psychiatrists and clinical psychologists through clinical evaluations (semi-structured clinical interviews: Spanish SCID-I). Depressive symptoms are assessed with the Beck Depression Inventory. Information on quality of life, level of physical activity, dietary habits, and blood, urine and stool samples are collected after the subject has agreed to participate in the study and once a year. To the best of our knowledge, the PREDI-DEP trial is the first ongoing randomized clinical trial designed to assess the role of the Mediterranean diet in the prevention of recurrent depression. It could be a cost-effective approach to avoid recurrence and improve the quality of life of these patients. The study has been prospectively registered in the U.S. National Library of Medicine ( https://clinicaltrials.gov ) with NCT number: NCT03081065.

Sections du résumé

BACKGROUND
The role of dietary patterns in the prevention of unipolar depression has been analyzed in several epidemiological studies. The primary aims of this study are to determine the effectiveness of an extra-olive oil-enriched Mediterranean diet in reducing the recurrence of depression and improving the symptoms of this condition.
METHODS
Multicenter, two-arm, parallel-group clinical trial. Arm 1, extra-virgin olive oil Mediterranean diet; Arm 2, control group without nutritional intervention. Dieticians are in charge of the nutritional intervention and regular contact with the participants. Contacts are made through our web platform ( https://predidep.es/participantes/ ) or by phone. Recurrence of depression is assessed by psychiatrists and clinical psychologists through clinical evaluations (semi-structured clinical interviews: Spanish SCID-I). Depressive symptoms are assessed with the Beck Depression Inventory. Information on quality of life, level of physical activity, dietary habits, and blood, urine and stool samples are collected after the subject has agreed to participate in the study and once a year.
DISCUSSION
To the best of our knowledge, the PREDI-DEP trial is the first ongoing randomized clinical trial designed to assess the role of the Mediterranean diet in the prevention of recurrent depression. It could be a cost-effective approach to avoid recurrence and improve the quality of life of these patients.
TRIAL REGISTRATION
The study has been prospectively registered in the U.S. National Library of Medicine ( https://clinicaltrials.gov ) with NCT number: NCT03081065.

Identifiants

pubmed: 30744589
doi: 10.1186/s12888-019-2036-4
pii: 10.1186/s12888-019-2036-4
pmc: PMC6371613
doi:

Substances chimiques

Olive Oil 0

Banques de données

ClinicalTrials.gov
['NCT03081065']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

63

Références

Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Proc Nutr Soc. 2016 May;75(2):139-46
pubmed: 26898781
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
BMC Med. 2015 Sep 17;13:197
pubmed: 26377327
Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):50-60
pubmed: 25940230
J Affect Disord. 2013 May 15;148(1):12-27
pubmed: 23415826
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
J Affect Disord. 2018 Jan 15;226:346-354
pubmed: 29031185
Eur J Nutr. 2018 Apr;57(3):1225-1235
pubmed: 28283824
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Nutr Neurosci. 2018 Sep;21(7):487-501
pubmed: 28424045
BMC Psychiatry. 2015 Jul 01;15:139
pubmed: 26129694
Nutr Neurosci. 2017 Apr;20(3):161-171
pubmed: 26317148
N Engl J Med. 2013 Apr 4;368(14):1279-90
pubmed: 23432189
J Clin Epidemiol. 2007 Jul;60(7):663-9
pubmed: 17573981
Am J Epidemiol. 2012 Feb 1;175(3):210-7
pubmed: 22262640
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Arch Gen Psychiatry. 2008 May;65(5):513-20
pubmed: 18458203
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
Stat Med. 2010 Apr 30;29(9):1037-57
pubmed: 20087875
BMC Med. 2013 Sep 20;11:208
pubmed: 24229349
Nutr Neurosci. 2019 Jul;22(7):474-487
pubmed: 29215971
Acta Psychiatr Scand Suppl. 2013;(443):38-54
pubmed: 23586875
Gac Sanit. 2005 Mar-Apr;19(2):135-50
pubmed: 15860162
Lancet Psychiatry. 2015 Mar;2(3):271-4
pubmed: 26359904
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408
Gerontologist. 1999 Aug;39(4):473-82
pubmed: 10495586
Arch Gen Psychiatry. 2009 Oct;66(10):1090-8
pubmed: 19805699
Am J Psychiatry. 2000 Feb;157(2):229-33
pubmed: 10671391
Br J Nutr. 2016 Jun;115(12):2145-53
pubmed: 27080555
BMC Psychiatry. 2016 Jun 08;16:192
pubmed: 27277946

Auteurs

A Sánchez-Villegas (A)

Nutrition Research Group, Research Institute of Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, Paseo Blas Cabrera Felipe Físico s/n, 35016, Las Palmas de Gran Canaria, Spain. almudena.sanchez@ulpgc.es.
Biomedical Research Center Network on Obesity and Nutrition (CIBERobn) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Madrid, Spain. almudena.sanchez@ulpgc.es.

B Cabrera-Suárez (B)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

P Molero (P)

Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain.
IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

A González-Pinto (A)

Psychiatry and Clinical Psychology Service, Hospital Universitario de Alava, Vitoria, Spain.
Biomedical Research Center Network on Mental Health (CIBERsam), Institute of Health Carlos III, Madrid, Spain.

C Chiclana-Actis (C)

Consulta Dr. Chiclana, Madrid, Spain.

C Cabrera (C)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

F Lahortiga-Ramos (F)

Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain.
IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

M Florido-Rodríguez (M)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

P Vega-Pérez (P)

Psychiatry and Clinical Psychology Service, Hospital Universitario de Alava, Vitoria, Spain.

R Vega-Pérez (R)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

J Pla (J)

Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain.
IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

M J Calviño-Cabada (MJ)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

F Ortuño (F)

Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain.
IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

S Navarro (S)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

Y Almeida (Y)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

J L Hernández-Fleta (JL)

Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH